Latest Breaking News On - Paradigm biocapital - Page 1 : comparemela.com

Half-year Report | Company Announcement

Investegate announcements from Half-year Report

United kingdomWilliam barlowJp morgan cazenoveDan higginsJohnson carmichaelChristopher getleyAboutmajedie investmentsHeinrich merzWilliam simmondsPraesidium strategic software opportunities offshore fundVf corporationJp morganShake shack incBreedon groupCameco corporationEvolent health inc

Acrivon Therapeutics Announces $130 Million Private Placement Financing

WATERTOWN, Mass, April 09, 2024 Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are.

United statesPeter blume jensenAlexandra santosDrug administrationExchange commissionAcrivon therapeutics incAcrivon predictive precision proteomicsPerceptive advisorsParadigm biocapitalSurveyor capitalSands capitalSecurities actFast trackBreakthrough devicePrivate securities litigation reform actMedia contacts

Acrivon Therapeutics (ACRV) Announces $130 Million Private Placement Financing

Acrivon Therapeutics (ACRV) Announces $130 Million Private Placement Financing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPeter blume jensenAcrivon therapeutics incExchange commissionAcrivon therapeuticsAcrivon predictive precision proteomicsPerceptive advisorsParadigm biocapitalSurveyor capitalSands capitalSecurities act

Acrivon To Privately Place $130 Mln Of Shares; Stock Soars In Pre-market

Acrivon Therapeutics, Inc. (ACRV), a firm focused on precision oncology medicines, announced on Tuesday that it has inked a deal for private investment in public equity or PIPE with certain investors to sell 8,235,000 shares at $8.

United statesPeter blume jensenAcrivon therapeutics incAcrivon therapeuticsPerceptive advisorsParadigm biocapitalSands capital

Obsidian Therapeutics Raises $160 5M in Series C Financing

Obsidian Therapeutics Raises $160 5M in Series C Financing
precisionmedicineonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from precisionmedicineonline.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandUnited kingdomMadan jagasiaNovo holdingsBristol myers squibbObsidian therapeuticsForesite capitalJanus henderson investorsParadigm biocapitalMassachusetts based obsidian